Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/18129Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Voulgaris, S. | en |
| dc.contributor.author | Nobes, J. P. | en |
| dc.contributor.author | Laing, R. W. | en |
| dc.contributor.author | Langley, S. E. | en |
| dc.date.accessioned | 2015-11-24T18:50:41Z | - |
| dc.date.available | 2015-11-24T18:50:41Z | - |
| dc.identifier.issn | 1476-5608 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18129 | - |
| dc.rights | Default Licence | - |
| dc.subject | Brachytherapy/*methods | en |
| dc.subject | Dose Fractionation | en |
| dc.subject | Follow-Up Studies | en |
| dc.subject | Humans | en |
| dc.subject | Male | en |
| dc.subject | Models, Biological | en |
| dc.subject | Patient Selection | en |
| dc.subject | Prostatectomy/methods | en |
| dc.subject | Prostatic Neoplasms/*radiotherapy | en |
| dc.subject | Quality of Life | en |
| dc.subject | Radiotherapy Dosage | en |
| dc.title | State-of-the-art: prostate LDR brachytherapy | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | 10.1038/pcan.2008.9 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/18364676 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2008 | - |
| heal.abstract | This article on low dose rate (LDR) prostate brachytherapy reviews long-term results, patient selection and quality of life issues. Mature results from the United States and United Kingdom are reported and issues regarding definitions of biochemical failure are discussed. Latest data comparing brachytherapy with radical prostatectomy or no definitive treatment and also the risk of secondary malignancies after prostate brachytherapy are presented. Urological parameters of patient selection and quality of life issues concerning urinary, sexual and bowel function are reviewed. The position of prostate brachytherapy next to surgery as a first-line treatment modality is demonstrated. | en |
| heal.journalName | Prostate Cancer Prostatic Dis | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
